Jane Tighe

1.2k total citations
19 papers, 781 citations indexed

About

Jane Tighe is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jane Tighe has authored 19 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Jane Tighe's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Myeloid Leukemia Research (4 papers). Jane Tighe is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Myeloid Leukemia Research (4 papers). Jane Tighe collaborates with scholars based in United Kingdom, United States and Denmark. Jane Tighe's co-authors include Chris Fegan, Guy Lucas, Ben Kennedy, David Oscier, M.J. Leach, Paul Moreton, Saad M. B. Rassam, Peter Hillmen, Andy C. Rawstron and Andrew Haynes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jane Tighe

18 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Tighe United Kingdom 8 432 380 274 254 224 19 781
Carmen Ruiz de Elvira France 9 430 1.0× 200 0.5× 349 1.3× 166 0.7× 427 1.9× 13 812
Kirsten Herbert Australia 14 251 0.6× 154 0.4× 271 1.0× 128 0.5× 210 0.9× 26 684
Randy Davis United States 10 448 1.0× 385 1.0× 108 0.4× 204 0.8× 128 0.6× 19 858
CY Li United States 10 317 0.7× 343 0.9× 197 0.7× 382 1.5× 164 0.7× 15 717
Fuensanta Millá Spain 15 238 0.6× 369 1.0× 524 1.9× 109 0.4× 219 1.0× 78 980
P Colombat France 18 463 1.1× 275 0.7× 265 1.0× 90 0.4× 389 1.7× 48 893
Donald Macdonald United Kingdom 19 350 0.8× 496 1.3× 532 1.9× 232 0.9× 140 0.6× 51 1.2k
Ryan Jacobs United States 12 190 0.4× 162 0.4× 182 0.7× 113 0.4× 176 0.8× 59 505
Tamara Intermesoli Italy 17 222 0.5× 331 0.9× 575 2.1× 178 0.7× 214 1.0× 46 1.0k
Allison Rosenthal United States 14 337 0.8× 151 0.4× 123 0.4× 103 0.4× 489 2.2× 121 822

Countries citing papers authored by Jane Tighe

Since Specialization
Citations

This map shows the geographic impact of Jane Tighe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Tighe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Tighe more than expected).

Fields of papers citing papers by Jane Tighe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Tighe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Tighe. The network helps show where Jane Tighe may publish in the future.

Co-authorship network of co-authors of Jane Tighe

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Tighe. A scholar is included among the top collaborators of Jane Tighe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Tighe. Jane Tighe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bowers, Margaret, A. J. CHARLTON, Jonathan Cullis, et al.. (2024). Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case series. SHILAP Revista de lepidopterología. 5(5). 987–991.
2.
Behrens, Judith, Gill Gaskin, Jonathan Barratt, et al.. (2022). What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial. SHILAP Revista de lepidopterología. 4(1). 246–250. 3 indexed citations
3.
Thein, Kyaw Zin, et al.. (2020). Efficacy of daratumumab combination regimen in patients with multiple myeloma: A combined analysis of phase III randomized controlled trials. SHILAP Revista de lepidopterología. 1(1). 262–266. 4 indexed citations
4.
Tighe, Jane, et al.. (2018). Primary meningococcal arthritis as a presentation of nodal marginal zone lymphoma. BMJ Case Reports. 2018. bcr–2017. 1 indexed citations
5.
Brewis, Melanie, et al.. (2014). Pulmonary Hypertension in Poems Syndrome: Resolution following Radiotherapy. Pulmonary Circulation. 4(4). 732–735. 4 indexed citations
6.
Rao, Ahsan, et al.. (2011). Bilateral cerebellopontine angle lesions not always NF2: diagnostic pitfall. British Journal of Neurosurgery. 26(2). 275–277. 5 indexed citations
7.
8.
D’Sa, Shirley, Niels Abildgaard, Jane Tighe, Penny Shaw, & Margaret Hall‐Craggs. (2007). Guidelines for the use of imaging in the management of myeloma. British Journal of Haematology. 137(1). 49–63. 64 indexed citations
9.
Marshall, Neil A., Dominic Culligan, Jane Tighe, et al.. (2007). The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma. Experimental Hematology. 35(4). 596–604. 39 indexed citations
10.
11.
12.
Moreton, Paul, Ben Kennedy, Guy Lucas, et al.. (2005). Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival. Journal of Clinical Oncology. 23(13). 2971–2979. 293 indexed citations
13.
Morris, Emma, Kirsty Thomson, Charles Craddock, et al.. (2004). Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood. 104(13). 3865–3871. 222 indexed citations
14.
Reilly, John T., et al.. (2003). Detection of cryptic MLL insertions using a commercial dual-color fluorescence in situ hybridization probe. Cancer Genetics and Cytogenetics. 147(1). 81–83. 15 indexed citations
15.
16.
Tighe, Jane, et al.. (2003). A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.. PubMed. 88(12). 1366–71. 5 indexed citations
17.
Robbie, L. A., Susan A. Berry, Nuala A. Booth, et al.. (2000). Myeloid leukaemic cells can lyse fibrin directly. British Journal of Haematology. 111(2). 524–529. 1 indexed citations
18.
Robbie, L. A., Susan A. Berry, Nuala A. Booth, et al.. (2000). Myeloid leukaemic cells can lyse fibrin directly. British Journal of Haematology. 111(2). 524–529. 5 indexed citations
19.
Tighe, Jane & Franco Calabi. (1995). t(8;21) Breakpoints are Clustered between Alternatively Spliced Exons of MTG8. Clinical Science. 89(3). 215–218. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Ruiz de Elvira Breakdown of academic impact, for papers by Kirsten Herbert Breakdown of academic impact, for papers by Randy Davis Breakdown of academic impact, for papers by CY Li Breakdown of academic impact, for papers by Fuensanta Millá Breakdown of academic impact, for papers by P Colombat Breakdown of academic impact, for papers by Donald Macdonald Breakdown of academic impact, for papers by Ryan Jacobs Breakdown of academic impact, for papers by Tamara Intermesoli Breakdown of academic impact, for papers by Allison Rosenthal
Rankless by CCL
2026